key: cord-0999720-xjgw436l
authors: Chen, Junrong; Peng, Xiang; Zhang, Min; Zhi, Min
title: Impact of medication discontinuation on patients with inflammatory bowel disease during the COVID-19 outbreak
date: 2020-06-15
journal: Gastroenterology
DOI: 10.1053/j.gastro.2020.05.087
sha: 0b9b06585e98d699a9e5e2d60b051c4656f69415
doc_id: 999720
cord_uid: xjgw436l

nan

impact on IBD patients.

We used the electronic medical record system to obtain the diagnosis and treatment information of outpatients and inpatients in the IBD Center of the Sixth Affiliated Hospital of Sun Yat-sen University, one of the largest IBD centers in South China.

From Jan. 23 2020 to Apr. 23, 2020, the number of registered IBD patients was 1294, which is 49.3% lower than that in the same period of 2019.

We then collected complete data of 386 IBD patients on maintenance therapy during the epidemic from patient record, telephone follow-up and questionnaires. The During the epidemic, our center provided guidance of IBD management via various platforms (WeChat official accounts, WeChat group and QQ group), and conducted online medical consultation and prescription. But the results of this survey showed the effect was not so satisfactory as we thought. During the epidemic, the chronic management strategy was challenged. Therefore, improvement is needed in information sharing, methods of drug purchase, adverse drug reaction monitoring and feedback route for the management strategy of IBD [6] [7] [8] . Telemedicine and community health services should also be promoted in the future [6] .

Inflammatory bowel diseases and COVID-19: the invisible enemy

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Inflammatory Bowel Disease Group of Chinese Society of Gastroenterology of Chinese Medical Association. Management of patients with inflammatory bowel disease during epidemic of novel coronavirus pneumonia

COVID-19 outbreak and inflammatory bowel disease management: a questionnaire survey from realistic practice

Prevention of COVID-19 in patients with inflammatory bowel disease in Wuhan, China

Challenges in the Care of IBD Patients During the CoViD-19 Pandemic: Report From a "Red Zone" Area in Northern Italy

AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary

Inflammatory bowel disease care in the COVID-19 pandemic era: the Humanitas, Milan experience